Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations
- 1 April 1996
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (4) , 414-421
- https://doi.org/10.1007/bf01247370
Abstract
Recently a new linker — hydrazinonicotinate (HYNIC) — was introduced for labelling of proteins and peptides with technetium-99m. HYNIC and other linkers have been used for labelling of human non-specific polyclonal immunoglobulin G (hIgG) with99mTc for the detection of infections. In this study we compared the tissue distribution of three different99mTc-hIgG preparations in groups of five Wistar rats with a focal intramuscular infection withStaphylococcus aureus. We compared99mTc-HYNIC-hIgG with99mTc-hIgG labelled via the so-called Schwarz method (reduction of disulphide bonds) and with the99mTc-labelled commercially available Technescan-HIG. Unlike the HYNIC linker, in the two other labelling methods free sulph-hydryl groups are involved in the binding of99mTc. High-performance liquid chromatography analysis of the labelled preparations and of plasma samples revealed aggregate or polymer formation in all three agents; this was least pronounced in the product labelled by means of the Schwarz method. The tested preparations did not show signs of degradation in vitro. The difference in linker chemistry was reflected in the tissue distribution. Thus the biodistribution of99mTc-HYNIC-hIgG was significantly different from the distribution of the two other preparations: abscess (1.4%±0.2%ID/g), muscle, liver, spleen, plasma, lung, bone marrow, and small intestine concentrations were higher at 24 h p.i.; kidney uptake (1.19%±0.08%ID/g) was significantly lower. The abscess-to-plasma and the abscess-to-muscle ratios (0.5 and 11, respectively), however, were in the same range for the three preparations tested. Quantitative analysis of the scintigraphs revealed that the total body clearance of99mTc-HYNIC-hIgG was significantly slower than for the other agents. The abscess uptake of99mTc-HYNIC-hIgG as a percentage of the remaining body activity was significantly higher. Based on its high abscess uptake, its low uptake in the kidneys and the high percentage of its abscess uptake in relation to the remaining body activity, we conclude that99mTc-HYNIC-hIgG seems superior to the two other preparations tested for the detection of infections.Keywords
This publication has 20 references indexed in Scilit:
- Comparative evaluation of 99Tcm-Hynic-HSA and 99Tcm-MAG3-HSA as possible blood pool agentsNuclear Medicine Communications, 1995
- Symposium abstract (continue in part II)Journal of Labelled Compounds and Radiopharmaceuticals, 1994
- Radioimmunoconjugates in the detection of infection and inflammationSeminars in Nuclear Medicine, 1993
- The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reductionNuclear Medicine Communications, 1992
- Preparation of hydrazino-modified proteins and their use for the synthesis of technetium-99m-protein conjugatesBioconjugate Chemistry, 1991
- 111In-Labeled Nonspecific Immunoglobulin Scanning in the Detection of Focal InfectionNew England Journal of Medicine, 1989
- Detection of acute inflammation with 111In-Labeled nonspecific polyclonal IgGSeminars in Nuclear Medicine, 1988
- Preparation of protein conjugates via intermolecular hydrazone linkageBiochemistry, 1986
- Renal radiopharmaceuticals—An updateSeminars in Nuclear Medicine, 1982
- Ellman's reagent: 5,5′-dithiobis(2-nitrobenzoic acid)—a reexaminationAnalytical Biochemistry, 1979